Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CROP-seq of hiPSC-derived astrocytes (bulk RNA-Seq)

ABSTRACT: CROP-seq of hiPSC-derived astrocytes (bulk RNA-Seq)

PROVIDER: PRJNA755724 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15503422.fastq.gz	Fastqsanger.gz
	SRR15503423.fastq.gz	Fastqsanger.gz
	SRR15503424.fastq.gz	Fastqsanger.gz
	SRR15503425.fastq.gz	Fastqsanger.gz
	SRR15503426.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

CROP-seq of hiPSC-derived astrocytes

Project description:CROP-seq of hiPSC-derived astrocytes

| PRJNA755719 | ENA

CROP-seq of hiPSC-derived astrocytes (scRNA-Seq)

Project description:CROP-seq of hiPSC-derived astrocytes (scRNA-Seq)

| PRJNA755725 | ENA

CROP-seq of hiPSC-derived astrocytes (bulk RNA-Seq)

Project description:In response to central nervous system injury or disease, astrocytes become reactive, adopting context-dependent states with altered functions. Certain inflammatory insults induce reactive astrocyte states that lose homeostatic functions and gain neurotoxicity, and likely contribute to neuroinflammatory and neurodegenerative diseases. However, the cellular pathways controlling these states are not fully understood. Here, we combined single-cell transcriptomics with CRISPRi screening in human iPSC-derived astrocytes to systematically interrogate inflammatory reactivity. We found that autocrine-paracrine IL-6 and interferon signaling downstream of canonical NF-kB activation drove two distinct inflammatory reactive states dependent on STAT3 and IRF1, respectively. Furthermore, these states corresponded with those observed in other experimental contexts, including in vivo, and their markers were upregulated in the human brain in Alzheimer's disease and ischemic-hypoxic encephalopathy. These results and the platform we established have the potential to guide the development of therapeutics to selectively modulate different aspects of inflammatory astrocyte reactivity.

2021-08-24 | GSE182307 | GEO

CROP-seq of hiPSC-derived astrocytes (scRNA-Seq)

2021-08-24 | GSE182308 | GEO

Bulk RNA-seq of human induced pluripotent stem cells (hIPSC) and neural progenitor cells (NPC) differentiated usind Dual SMAD inhibition using the prime-seq method

Project description:Five hiPSC lines from four individuals were differentiated to neural progenitor cells. The two cell types were compared in regards to marker gene expression of known cell type markers to show that the used bulk RNA-seq protocol, called prime-seq can capture known biological differences.

2021-08-01 | E-MTAB-10133 | biostudies-arrayexpress

Multi-omic analyses of hiPSC-derived astrocytes during differentiation

Project description:Astrocytes are essential players in brain development and functions, being particularly relevant as regulators of energy metabolism, ionic homeostasis, and synaptic transmission. They are also the major source of L-serine (L-Ser) in the brain, which is synthesized from the glycolytic intermediate 3-phosphoglycerate through the phosphorylated pathway (PP), which comprises 3- phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase (PSAT) and phosphoserine phosphatase (PSP). L-Ser is the precursor of the two main co-agonists of the N-methyl-D-aspartate receptors, glycine and D-serine. Remarkably, astrocytes also contribute to neurodegenerative disorders by various mechanisms, including metabolic alterations. We generated human mature astrocytes from pluripotent stem cells (hiPSC) to get a picture of the changes that occur during astrocytes differentiation and here we report the metabolic rewiring occurring during differentiation. We have recently reported that the levels of the enzymes of the PP are increased in Alzheimer’s disease brains. Following this observation, we overexpressed PHGDH, PSAT or PSP in the hiPSC-derived astrocyte model and significant metabolic alterations were apparent. These results provide a valuable model for developing potential novel approaches to address brain diseases, especially those related to serine metabolism alterations. By exploiting the potential of hiPSCs, we studied the cellular processes timely involved in the differentiation program. The molecular understanding of astrocyte differentiation from NSCs is an important aspect to consider for modulating astrocyte physiology in human pathologies and for developing potential therapeutic strategies. By overexpressing the enzymes of the PP pathway, we demonstrated that this model is a valuable tool for developing potential novel approaches to address brain diseases, especially those related to serine metabolism alterations.

2025-08-25 | PXD045073 | Pride

CROP-seq of hiPSC-derived astrocytes

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-08-24 | GSE182309 | GEO

CROP-seq + PIP-seq

Project description:CROP-seq + PIP-seq

| PRJNA923463 | ENA

Bulk RNAseq analysis of hypertrophic cardiomyopathy (HCM) hiPSC-derived cardiomyocytes (hiPSC-CMs) and the isogenic control

Project description:To investigate HCM mutation-associated molecular details at the early stage of disease development, we performed bulk RNA-seq analysis at Day 15 of differentiation using RNA isolated from the isogenic control and mutant hiPSC-CMs. We performed pair-end sequencing with >30 million reads per sample with clean read counts of more than 96% for each sample.

2022-07-06 | GSE198258 | GEO

Bulk RNA-seq of FACS sorted astrocytes upon microglial depletion

Project description:Bulk RNA-seq of FACS sorted astrocytes upon microglial depletion

| PRJNA719128 | ENA